IMPACT OF RENAL SYMPATHETIC DENERVATION ON RENAL FUNCTIONAL RESERVE IN HYPERTENSIVE PATIENTS - STUDY DESIGN AND PRELIMINARY DATA

Objective: To search the impact of catheter-based renal sympathetic denervation (RDN) on renal functional reserve (RFR) in patients with essential hypertension with normal renal function or chronic renal disease with an estimated glomerular filtration rate (eGFR)>=30 ml/min/1.73m2. Design and method: Patients with essential, uncontrolled hypertension either under antihypertensive treatment with one drug class or naive from antihypertensive treatment, with normal renal function or chronic kidney disease (CKD) up to stage IIIb (eGFR >=30 ml/min/1.73m2) are eligible for enrollment. RFR is estimated before and three months after RDN. In addition, the urine albumin/creatinine ratio (UACR) and 24-hour urine protein after 24-hour home urine collection are measured at the same time points.Results: Twelve patients were enrolled and completed follow-up three months after RDN. Three patients had stage 2 CKD. 25% of patients had microalbuminuria. At baseline, RFR in 75% of patients was below the normal value. eGFR did not change significantly after RDN (p=0.19). There was a trend towards decrease in UACR and 24-hour urine protein (p=0.17) and a trend towards increase in RFR value three months post-RDN (p=0.11). Table 1 - baseline characteristics Age (mean, years): 54 Male sex (n, %): 11 (92%) Chronic kidney disease (n, %) Stage 1: 9 (75%) Stage 2: 3 (25%) Table 2 - clinical data ABPM (mean, mmHg): 154/107 eGFR (ml/min/1.73m2): 98 24-hour urine protein (range, mg/24 h) (pre-RDN): 56-204 (post-RDN): 51-184.8 RFR (range, ml/min/1.73m2) (pre-RDN): 14.2-39.7 (post-RDN): 15.7-62.8 Conclusions: In this initial part of our protocol, there was a trend towards decrease in UACR and 24-hour urine protein and a numerical trend towards increase in RFR value three months post-RDN. Four patients with stage 3 CKD were also enrolled in our study, however, follow-up is pending. Patients are still enrolled and data on larger pool are anticipated.

Authors

Institutions

Publication Details

Journal
Journal of Hypertension
Published
2025-05-01
DOI
https://doi.org/10.1097/01.hjh.0001116304.67780.7e
Primary Topic
Blood Pressure and Hypertension Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

IMPACT OF RENAL SYMPATHETIC DENERVATION ON RENAL FUNCTIONAL RESERVE IN HYPERTENSIVE PATIENTS - STUDY DESIGN AND PRELIMINARY DATA

Athanasios Sakalidis, Kyriakos Dimitriadis, Vasileios Mantziaris, Dimitrios Konstantinidis et al.
Journal of Hypertension
Blood Pressure and Hypertension Studies
article

IMPACT OF RENAL SYMPATHETIC DENERVATION ON RENAL FUNCTIONAL RESERVE IN HYPERTENSIVE PATIENTS - STUDY DESIGN AND PRELIMINARY DATA

Athanasios Sakalidis, Kyriakos Dimitriadis, Vasileios Mantziaris, Dimitrios Konstantinidis, Konstantinos Tsioufis, Maria Stathoulopoulou, Andreas Mavroudis, Fotios Tatakis
article en

Abstract

Objective: To search the impact of catheter-based renal sympathetic denervation (RDN) on renal functional reserve (RFR) in patients with essential hypertension with normal renal function or chronic renal disease with an estimated glomerular filtration rate (eGFR)>=30 ml/min/1.73m2. Design and method: Patients with essential, uncontrolled hypertension either under antihypertensive treatment with one drug class or naive from antihypertensive treatment, with normal renal function or chronic kidney disease (CKD) up to stage IIIb (eGFR >=30 ml/min/1.73m2) are eligible for enrollment. RFR is estimated before and three months after RDN. In addition, the urine albumin/creatinine ratio (UACR) and 24-hour urine protein after 24-hour home urine collection are measured at the same time points.Results: Twelve patients were enrolled and completed follow-up three months after RDN. Three patients had stage 2 CKD. 25% of patients had microalbuminuria. At baseline, RFR in 75% of patients was below the normal value. eGFR did not change significantly after RDN (p=0.19). There was a trend towards decrease in UACR and 24-hour urine protein (p=0.17) and a trend towards increase in RFR value three months post-RDN (p=0.11). Table 1 - baseline characteristics Age (mean, years): 54 Male sex (n, %): 11 (92%) Chronic kidney disease (n, %) Stage 1: 9 (75%) Stage 2: 3 (25%) Table 2 - clinical data ABPM (mean, mmHg): 154/107 eGFR (ml/min/1.73m2): 98 24-hour urine protein (range, mg/24 h) (pre-RDN): 56-204 (post-RDN): 51-184.8 RFR (range, ml/min/1.73m2) (pre-RDN): 14.2-39.7 (post-RDN): 15.7-62.8 Conclusions: In this initial part of our protocol, there was a trend towards decrease in UACR and 24-hour urine protein and a numerical trend towards increase in RFR value three months post-RDN. Four patients with stage 3 CKD were also enrolled in our study, however, follow-up is pending. Patients are still enrolled and data on larger pool are anticipated.

Journal of HypertensionVol. 43(Suppl 1)
Hippocration General Hospital (GR)
Zero hunger
Openalex Percentile: Top 80%
Blood Pressure and Hypertension Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.